Literature DB >> 27207680

Understanding walking activity in multiple sclerosis: step count, walking intensity and uninterrupted walking activity duration related to degree of disability.

An Neven1, Annelien Vanderstraeten2, Davy Janssens3, Geert Wets3, Peter Feys4.   

Abstract

In multiple sclerosis (MS), physical activity (PA) is most commonly measured as number of steps, while also walking intensity and walking activity duration are keys for a healthy lifestyle. The aim of this study was to investigate (1) the number of steps persons with MS (PwMS) take; (2) the number of steps they take at low and moderate intensity; and (3) their walking activity duration for 2, 3, 6, 10, 12 and 14 uninterrupted minutes; all related to the degree of disability. 64 PwMS participated, distinguished in a mild (n = 31) and moderate MS subgroup (n = 34) based on their ambulatory dysfunction (Disease Steps). Standardized clinical tests were performed, and step data from the StepWatch Activity Monitor were collected for seven consecutive days. The results showed that (1) step count in PwMS was lower than PA recommendations, and is negatively influenced by a higher disability degree. (2) No walking was registered during 77 % of the day. PwMS are making steps for 22 % at low and only 1 % at moderate intensity. (3) Both MS subgroups rarely walk for more than six uninterrupted minutes, especially not at moderate intensity. PwMS need to be encouraged to make steps at moderate intensity, and to make steps for longer periods of time (minimal ten uninterrupted minutes).

Entities:  

Keywords:  Multiple sclerosis; Physical activity; Walking

Mesh:

Year:  2016        PMID: 27207680     DOI: 10.1007/s10072-016-2609-7

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.307


  42 in total

1.  Physical activity and multiple sclerosis: a meta-analysis.

Authors:  Robert W Motl; Edward McAuley; Erin M Snook
Journal:  Mult Scler       Date:  2005-08       Impact factor: 6.312

2.  Multiple sclerosis relapses are not associated with exercise.

Authors:  A Tallner; A Waschbisch; I Wenny; S Schwab; C Hentschke; K Pfeifer; M Mäurer
Journal:  Mult Scler       Date:  2011-07-06       Impact factor: 6.312

3.  Steps per day among persons with multiple sclerosis: variation by demographic, clinical, and device characteristics.

Authors:  Deirdre Dlugonski; Lara A Pilutti; Brian M Sandroff; Yoojin Suh; Swathi Balantrapu; Robert W Motl
Journal:  Arch Phys Med Rehabil       Date:  2013-02-15       Impact factor: 3.966

4.  Predicting habitual walking performance in multiple sclerosis: relevance of capacity and self-report measures.

Authors:  Domien Gijbels; Geert Alders; Elke Van Hoof; Caroline Charlier; Machteld Roelants; Tom Broekmans; Bert Op 't Eijnde; Peter Feys
Journal:  Mult Scler       Date:  2010-03-05       Impact factor: 6.312

5.  Objectively quantified physical activity in persons with multiple sclerosis.

Authors:  Rachel E Klaren; Robert W Motl; Deirdre Dlugonski; Brian M Sandroff; Lara A Pilutti
Journal:  Arch Phys Med Rehabil       Date:  2013-07-29       Impact factor: 3.966

6.  Reliability of scores from physical activity monitors in adults with multiple sclerosis.

Authors:  Robert W Motl; Weimo Zhu; Youongsik Park; Edward McAuley; Jennifer A Scott; Erin M Snook
Journal:  Adapt Phys Activ Q       Date:  2007-07       Impact factor: 2.929

7.  Accelerometry in persons with multiple sclerosis: measurement of physical activity or walking mobility?

Authors:  Madeline Weikert; Robert W Motl; Yoojin Suh; Edward McAuley; Daniel Wynn
Journal:  J Neurol Sci       Date:  2010-01-08       Impact factor: 3.181

8.  Home-based system for physical activity monitoring in patients with multiple sclerosis (Pilot study).

Authors:  Layal Shammas; Tom Zentek; Birte von Haaren; Stefan Schlesinger; Stefan Hey; Asarnusch Rashid
Journal:  Biomed Eng Online       Date:  2014-02-06       Impact factor: 2.819

9.  Accuracy of StepWatch™ and ActiGraph accelerometers for measuring steps taken among persons with multiple sclerosis.

Authors:  Brian M Sandroff; Robert W Motl; Lara A Pilutti; Yvonne C Learmonth; Ipek Ensari; Deirdre Dlugonski; Rachel E Klaren; Swathi Balantrapu; Barry J Riskin
Journal:  PLoS One       Date:  2014-04-08       Impact factor: 3.240

10.  The impact of regular physical activity on fatigue, depression and quality of life in persons with multiple sclerosis.

Authors:  Nicole M Stroud; Clare L Minahan
Journal:  Health Qual Life Outcomes       Date:  2009-07-20       Impact factor: 3.186

View more
  5 in total

1.  Advances in clinical neurology through the journal "Neurological Sciences" (2015-2016).

Authors:  Ilaria Di Donato; Antonio Federico
Journal:  Neurol Sci       Date:  2017-01       Impact factor: 3.307

2.  Validation of the 2-Minute Walk Test with the 6-Minute Walk Test and Other Functional Measures in Persons with Multiple Sclerosis.

Authors:  David A Scalzitti; Kenneth J Harwood; Joyce R Maring; Susan J Leach; Elizabeth A Ruckert; Ellen Costello
Journal:  Int J MS Care       Date:  2018 Jul-Aug

3.  Does gait bout definition influence the ability to discriminate gait quality between people with and without multiple sclerosis during daily life?

Authors:  Vrutangkumar V Shah; James McNames; Graham Harker; Carolin Curtze; Patricia Carlson-Kuhta; Rebecca I Spain; Mahmoud El-Gohary; Martina Mancini; Fay B Horak
Journal:  Gait Posture       Date:  2020-11-25       Impact factor: 2.840

4.  Influence of physical activity on serum vitamin D levels in people with multiple sclerosis.

Authors:  Angelika Bauer; Ivan Lechner; Michael Auer; Thomas Berger; Gabriel Bsteh; Franziska Di Pauli; Harald Hegen; Sebastian Wurth; Anne Zinganell; Florian Deisenhammer
Journal:  PLoS One       Date:  2020-06-11       Impact factor: 3.240

5.  The Two-Minute Walk Test in Persons with Multiple Sclerosis: Correlations of Cadence with Free-Living Walking Do Not Support Ecological Validity.

Authors:  Viktoria Karle; Verena Hartung; Keti Ivanovska; Mathias Mäurer; Peter Flachenecker; Klaus Pfeifer; Alexander Tallner
Journal:  Int J Environ Res Public Health       Date:  2020-12-04       Impact factor: 3.390

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.